C07C 311/10
Of a saturated carbon skeleton containing rings
Official title: of a saturated carbon skeleton containing rings
C07C311/10 (Of a saturated carbon skeleton containing rings) appears on 76 US grants and 76 published applications in this corpus.
Search patents in C07C- Granted patents
- 76
- Published applications
- 76
- Assignees
- 49
- Inventors
- 211
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 5 | 3 |
| 2003 | 1 | 2 |
| 2004 | 2 | 3 |
| 2005 | 2 | 2 |
| 2006 | 1 | 2 |
| 2007 | 2 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 3 | 4 |
| 2011 | 0 | 1 |
| 2012 | 2 | 8 |
| 2013 | 4 | 3 |
| 2014 | 7 | 6 |
| 2015 | 7 | 3 |
| 2016 | 2 | 1 |
| 2017 | 1 | 5 |
| 2018 | 4 | 3 |
| 2019 | 4 | 6 |
| 2020 | 5 | 6 |
| 2021 | 5 | 2 |
| 2022 | 2 | 3 |
| 2023 | 0 | 3 |
| 2024 | 2 | 1 |
| 2025 | 3 | 3 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Herbicidal malonamides28 Apr 2026US 12,612,394 B2BASF SE
- Phenylalanine-based LAT1 inhibitors and uses thereof30 Sep 2025US 12,427,124 B1Maxymune Therapeutics, Inc.
- Modulators of sestrin-GATOR2 interaction and uses thereof5 Aug 2025US 12,378,263 B2Navitor Pharmaceuticals, Inc.
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-1715 Jul 2025US 12,358,866 B2Reata Pharmaceuticals Holdings, LLC
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto2 Apr 2024US 11,944,099 B2Corteva Agriscience LLC
- Composite material, preparation method thereof and photoelectric device30 Jul 2026US 2026/0223589 A1Tcl Technology Group Corporation
- Modulators of sestrin-gator2 interaction and uses thereof26 Feb 2026US 2026/0055122 A1Navitor Pharmaceuticals, Inc.
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-1720 Nov 2025US 2025/0353813 A1Reata Pharmaceuticals Holdings, LLC
- Phenylalanine-based lat1 inhibitors and uses thereof6 Nov 2025US 2025/0339388 A1Maxymune Therapeutics, Inc.
- Phenylalanine-based lat1 inhibitors and uses thereof16 Oct 2025US 2025/0319046 A1Maxymune Therapeutics, Inc.
Most cited
By later US patents
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists88US 5,780,483 ASmithKline Beecham Corporation · 1998
- IL-8 receptor antagonists76US 6,262,113 B1SmithKline Beecham Corporation · 2001
- Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient54US 6,448,290 B1Ono Pharmaceutical Co., Ltd. · 2002
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-1750US 8,124,799 B2Reata Pharmaceuticals, Inc. · 2012